期刊文献+

血管内皮生长因子基因表达定量分析方法的建立及其应用

Quantitative Analysis of Gene Expression for Vascular Endothelial Growth Factor and Its Application
下载PDF
导出
摘要 血管内皮生长因子(VEGF)是血管新生的中枢介质,在白血病的病理机制中具有重要作用,也是血液肿瘤患者一种独立的预后因素,但VEGF在白血病细胞分化或凋亡中的重要性尚待阐明。为了查明VEGF在白血病细胞分化或凋亡中的作用,构建了VEGF基因竞争模板(T-VEGFΔ)并建立竞争性定量逆转录聚合酶链反应(cQRT-PCR),以监测全反式维甲酸(ATRA)诱导NB4细胞分化过程中VEGF基因表达的改变;通过将系列稀释的靶分子与恒量的竞争模板共扩增,获得标准曲线,用于计算待测样本中靶基因的分子数;在不同时间点分别检测NB4细胞的CD11b抗原表达和NBT还原率。结果显示:cQRT-PCR可作为定量分析VEGF基因表达的有效工具,其测定范围约为1×104-2×105分子。NB4细胞经ATRA处理0、12、24和48小时后,其VEGF基因转录本的数量分别为42.3×105、12.6×105、3.6×105,低于1.0×105/μg总RNA,并伴有CD11b表达上调和NBT还原率增加。结论:成功地建立了cQRT-PCR方法,证明ATRA显著抑制VEGF表达并可能通过抑制血管新生发挥抗白血病的功效。 Vascular endothelial growth factor (VEGF), a central mediator of angiogenesis, not only plays an important role in the pathogenesis of leukemia, but also is an independent prognostic factor in patients with hematologic malignancies, like those in solid tumors. However, the importance of VEGF during differentiation or apoptosis of leukemia cells remains to be elucidated. In order to assess the alternation of VEGF gene expression in the process of alltrans retinoic acid ( ATRA )-induced differentiation of NIM acute promyelocytic leukemia cell line, and a competitor DNA fragment, VEGF gene competative template (T-VEGF△) was constructed by using gene recombinant technologies, and a competitive quantitative reverse transcriptase-polymerase chain reaction (cQRT-PCR) method was developed. A standard curve was obtained by co-amplification of serial dilutions of the target nulecules with constant amount of competitive template and this curve was used to detect molecular number of target gene in measuring sample.The surface expression of CD1 lb antigen and nitroblue tetrazolium (NBT) reduction rate of NB4 cells were also assayed at different time points. The results showed that cQRT-PCR was a sensitive, reliable tool for analysis of VEGF gene expression with a detectable range from 1 × 10^4 to 2 × 10^5 molecules. The number of VEGF gene transcripts detected by means of cQRT-PCR assay was 42.3 × 10%5, 12.6 × 10^5, 3.6 × 10^5, and less than 1.0 × 10^5/μg total RNA at 0,12, 24 and 48 hours after ATRA treatment, respectively. This rapid down-regulation of VEGF gene expression, during ATRA-induced NB4 cell differentiation, was accompanied by the up-regulation of CD11b expression and an increased NBT reduction rate. In conclusion, cQRT-PCR method was successtully constructed, confirming that ATRA efficiently repressed VEGF, at the same time, the ATRA might exert an antileukemic effect, other than induction of differentiation via inhibition of angiogenesis.
出处 《中国实验血液学杂志》 CAS CSCD 2005年第4期548-552,共5页 Journal of Experimental Hematology
基金 江苏省科技厅社会发展项目(BS2001070) 江苏省教育厅自然科学研究基金(02KJB320002)部分资助
关键词 血管内皮生长因子 cQRT—PCR 基因表达 细胞分化 全反式维甲酸 NB4细胞 vascular endothelial growth factor cQRT-PCR gene expression cell differentiation ATRA NB4 cell
  • 相关文献

参考文献14

  • 1Bautz F, Rafii S, Kanz L, et al. Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells. Possible role in the hematopoietic microenvironment. Exp Hematol, 2000; 28: 700 - 706.
  • 2Bertolini F, Mancuso P, Gobbi A, et al. The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp Hematol, 2000;28:993 - 1000.
  • 3Padro T, Bieker R, Ruiz S, et al. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.Leukemia, 2002; 16:1302 - 1310.
  • 4Aguayo A, Estey E, Kantarjian H, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood, 1999; 94:3717 - 3721.
  • 5Dias S, Hattori K, Heissig B, et al. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA. 2001; 98:10857 - 10862.
  • 6王玲,陈子兴,傅建新,岑建农,王玮.NB4细胞系诱导分化过程中WT1基因表达的变化[J].中国实验血液学杂志,2001,9(2):128-131. 被引量:4
  • 7傅建新,王玮,王玲,周幽心,阮长耿,陈子兴.造血细胞表达血管内皮生长因子及其受体基因的研究[J].江苏医药,2001,27(4):246-246. 被引量:2
  • 8Dias S, Hattori K, Zhu Z, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest,2000; 106:511-521.
  • 9Schuch G, Machluf M, Bartsch G, et al. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood, 2002; 100: 4622 - 4628.
  • 10Liu TX, Zhang JW, Tao J, et al. Gene expression networks underlying retinoic acid - induced differentiation of acute promyelocytic leukemia cells. Blood, 2000; 96:1496 - 1504.

二级参考文献9

  • 1Sekiya M, Adachi M, Hinoda Y, et al. Downregulation of Wilms′ tumor gene (WT1) during myelomonocytic differentiation in HL60 cells. Blood, 1994; 83:1876 - 1882
  • 2Phelan SA, Lindberg C, Call KM. Wilms′ tumor gene, WT1, mRNA is down regulated during induction of erythroid and megakaryocytic differentiation of K562 cells. Cell Growth Differ, 1994; 5:677-686
  • 3Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wlims′ tumor locus. Cell, 1990; 60:509-520
  • 4Bergmann L, Miething C, Maurer U, et al. High levels of Wlims′ tumor gene (WT1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood, 1997; 90:1217- 1225
  • 5Goodyer P, Dehbi M, Torban E, et al. Repression of the retinoic acid receptor-alpha gene by the Wilms′ tumor sup pressor gene product, WT1. Oncogene, 1995; 10:1125-1129
  • 6曹丽萍,王斌,郁知非.MRP基因定量RT-PCR内标准DNA模板和RNA模板的构建[J].中华血液学杂志,1998,19(5):250-253. 被引量:5
  • 7王玮,岑建农,李建勇,王阳,傅建新,潘金兰,陈子兴.地高辛掺入聚合酶链反应检测白血病多药耐药基因[J].中华医学检验杂志,1999,22(2):109-111. 被引量:3
  • 8傅建新,王玲,白霞,王玮,奚晓东,陈子兴,阮长耿.T-载体在聚合酶链反应扩增产物克隆中的应用[J].苏州医学院学报,2000,20(3):221-223. 被引量:3
  • 9傅建新,王玮,卢大儒,岑建农,陈子兴.增强型绿色荧光蛋白逆转录病毒载体的构建和表达[J].中国实验血液学杂志,2000,8(4):261-265. 被引量:9

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部